SCHEMBL7676555

SCHEMBL7676555

Clc1c[c]cc(N2CCOCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ KMT2A Q03164 5/20 0.46
▸ MEN1 O00255 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ AR P10275 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ CNR2 P34972 3/20 0.38
▸ POLB P06746 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679009 0.83 CYP1A2 (0.44) CYP1A2CYP2D6KMT2AMEN1CRHBP
SCHEMBL7679217 0.81 CYP1A2 (0.47) CYP1A2CYP2D6KMT2AMEN1CRHBP
SCHEMBL4781313 0.79 KMT2A (0.51) CYP1A2CYP2D6MAPTKMT2AMEN1
SCHEMBL5897129 0.77 HRH4 (0.55) CYP1A2KMT2ACRHBPCRHR2
SCHEMBL7675604 0.74 MAPT (0.45) CYP1A2CYP2D6MAPTKMT2AMEN1
SCHEMBL5896965 0.73 HRH3 (0.43) MAPTKMT2ARAB9ACRHBPCRHR2
SCHEMBL3089415 0.73 KMT2A (0.64) CYP1A2CYP2D6MAPTKMT2AMEN1
SCHEMBL29434159 0.73 MAPT (0.65) CYP1A2CYP2D6MAPTKMT2AMEN1
SCHEMBL29434160 0.73 MAPT (0.65) CYP1A2CYP2D6MAPTKMT2AMEN1
SCHEMBL30818941 0.73 HTR3E (0.64) CYP1A2CYP2D6MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0196005-B1 PYRIDAZINONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1989-12-20 — — EP claimed
CN-112189012-B Trisubstituted aryl and heteroaryl derivatives as modulators of PI3 kinase and autophagy pathways 神经孔疗法股份有限公司 2024-02-13 — — CN disclosed
CN-112189012-A Trisubstituted aryl and heteroaryl derivatives as modulators of PI3 kinase and autophagy pathways 神经孔疗法股份有限公司 2021-01-05 — — CN disclosed
CN-102625708-A Pi3 kinase inhibitors and uses thereof AVILA THERAPEUTICS INC 2012-08-01 — — CN disclosed
CN-1146542-C Benzamide derivatives and their use as cytokine inhibitors — 2004-04-21 — — CN disclosed
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
CN-1319092-A Benzamide derivatives and their use as cytokine inhibitors ASTRAZENECA AB (SE) 2001-10-24 — — CN disclosed
EP-0196005-B1 PYRIDAZINONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1989-12-20 — — EP disclosed
US-4831027-A USEFUL IN TREATMENT OF CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1989-05-16 — — US disclosed
EP-0196005-A1 Pyridazinones, their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1986-10-01 — — EP disclosed
EP-0196005-A1 Pyridazinones, their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1986-10-01 — — EP disclosed
Send feedback